Mentor Capital (MNTR) Focuses Investment in Cancer Immunotherapy Index Companies

Mentor Capital, Inc. invests across all Companies in its proprietary Cancer Immunotherapy Index and seeks to overweight acquisition or stock purchase funding in those companies with the greatest promise.   Index detail at CI Index icon.

Mentor Capital strategic plans to apply MNTRs possible $125 Million in warrant proceeds are pivoting to keep pace with rapidly changing investment and acquisition opportunities in this sector.  See Changing Assets & Acquisitions.